Kenneth Sherman, MD
Transplant Hepatology · Cincinnati, OHNPI 1639137144
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $41,298 of the $42,798 with a category attached, or 96.5%. 5 manufacturers reported payments, led by Amgen at 40.0% of the total. Reporting peaked in 2021 at $16,763 and has fallen 68.7% since, to $5,250 in 2024.
Across 24 payments — averaging $1783.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$17K
- Gilead$12K
- AbbVie$7K
- Theratechnologies Inc.$5K
- Novo Nordisk$3K
Across 106 payments — averaging $2329.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Intercept Pharmaceuticals, Inc.$88K
- AbbVie$77K
- Gilead$57K
- Intercept Pharma Europe Ltd.$21K
- Merck$4K
What the payments were for
- Consulting fees$41,29896%
- Speaking & faculty fees$1,5004%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 12 | $17,125 |
| Gilead | 4 | $11,640 |
| AbbVie | 5 | $6,821 |
| Theratechnologies Inc. | 2 | $4,500 |
| Novo Nordisk | 1 | $2,713 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UPLIZNA$13,625
How this compares
Too few transplant hepatology providers in Ohioto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant hepatology in Cincinnati
- Khurram BariCincinnati$124K
- Alexander LalosCincinnati$15K
- Nadeem AnwarCincinnati$5K
- Amoah Yeboah-KorangCincinnati$246
- Anthony MichaelsColumbus$380K
- Pranav PennintiColumbus$563
- Ruchi BhatiaColumbus$374
- Naemat SandhuCleveland$262
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.